Brief: MiMedx Q4 Sales USD 118.095 Million Vs. IBES Estimate USD 106.8 Million
25/02/2026 21:01
Feb 25 (Reuters) - MiMedx Q4 adjusted EBITDA USD 29.375 million vs. IBES estimate USD 25.9 million. Q4 gross profit USD 99.04 million Q4 net income USD 15.191 million Q4 operating income USD 21.078 million outlook FY sales USD 340-360 million
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million